Navigation Links
Supplemental Oxygen Company Offers Steps to Improve COPD Patients' Lives

AUSTIN, Texas, Aug. 19 /PRNewswire/ -- What is the fourth leading cause of death in the United States? Many would be surprised to learn that chronic obstructive pulmonary disease (COPD) is, and the number of people with COPD is increasing. According to the COPD Foundation, more than 12 million Americans are currently diagnosed with COPD and an additional 12 million may not realize their shortness of breath and coughing are in fact symptoms of this debilitating condition.

Although such symptoms can begin as a mild annoyance, they can get worse with time. Eventually patients find themselves short of breath doing simple activities, like preparing a meal or getting dressed.

But there is reason for hope.

Once diagnosed with COPD, often also referred to as emphysema or chronic bronchitis, there are multiple treatment options and ways to manage the disease and improve one's quality of life.  

The COPD Foundation offers multiple tips for better breathing and managing the often debilitating disease.

  • Avoid triggers and exposure to pollutants - Stay away from things such as dust, strong fumes and cigarette smoke that could irritate your lungs. Also, stay indoors as much as possible when the outside air quality is poor. It is best to avoid crowds during flu season and it is a good idea to get an annual flu shot.
  • Try various breathing techniques such as:
  • Pursed-lip breathing - Inhale through your nose for four seconds. Then exhale through your mouth for six-to-eight seconds, with your lips almost closed.
  • Belly breathing - Breathing with your diaphragm makes more space for your lungs to take in air.
  • Bend forward - Bending at the waist helps the diaphragm move more easily, allowing more air to fill the lungs. You can sit or stand with this technique, as long as you lean slightly forward from the waist, keeping your back straight.
  • Consider a change in lifestyle
  • Eat well - It is especially important for a COPD sufferer to eat a well balanced diet. Emphysema patients tend to be very thin and should include plenty of nutrients and supplements in their diet. Bronchitis patients on the other hand may be overweight, which places extra burden on the lungs.
  • Quit smoking - It is never too late to kick the habit.

  • Changing lifestyle habits, avoiding triggers and practicing breathing techniques may only go so far. A physician may recommend oxygen therapy for patients with severe COPD. To some, oxygen therapy is viewed as a death sentence because they think of the heavy oxygen tanks that must be wheeled behind them. Oxygen therapy patients no longer need to view their supplemental oxygen prescription as a homebound sentence. Bulky oxygen tanks and carts may one day be obsolete thanks to the LifeChoice® Oxygen Concentrator, a new home medical product for supplemental oxygen users.

    "It is lighter and more compact than anything that I have seen," Dr. Robert Emerson, Chief of Pulmonary Medicine at the Austin Diagnostic Clinic, said.  "As a pulmonary specialist who sees many COPD patients weekly, I notice a tremendous difference in those who use a portable oxygen concentrator, such as the LifeChoice®, versus those who lug around heavy tanks."

    LifeChoice by Inova Labs is the smallest stationary and portable oxygen concentrator available, weighing less than five pounds. It offers true mobility for its users and allows them the freedom to again experience simple joys such as walking outside without cumbersome equipment.

    "We have had numerous patients send us personal thank you notes expressing their deep gratitude for inventing something that has transformed how they live with COPD," David Shockley Jr., Inova Labs president, said.

    The LifeChoice, with the patent pending Sleep Mode technology, is the only portable concentrator system designed with endless oxygen pulse for round-the-clock use.

    For additional information, visit or call the customer care center at 1-877-490-3339.

    About Inova LabsInova Labs, which was founded in 2002, is a medical device development, manufacturer and worldwide distribution company primarily focused on direct patient care products. Inova Labs invented, developed, owns, manufactures and is the exclusive worldwide master distributor of the LifeChoice portable oxygen concentrator. The LifeChoice is revolutionizing oxygen therapy and patient freedom. Inova Labs is an FDA-registered company and fully ISO 13485 compliant utilizing state-of-the-art manufacturing systems. Inova Labs, Inc., along with its manufacturing factory, is headquartered, in Austin, Texas, where the LifeChoice is made.Contact: Lindsey Elbom or Meredith Michelson, or mmichelson@echristianpr.comElizabeth Christian & Associates Public RelationsAvailable Topic Expert(s): For information on the listed expert(s), click appropriate link.

    David Shockley

    SOURCE Inova Labs
    Copyright©2010 PR Newswire.
    All rights reserved

    Related medicine technology :

    1. FDA Approves Labeling Change for Vyvanse(R) (lisdexamfetamine dimesylate) Capsules CII to Include Supplemental Data Demonstrating Significant Efficacy at Two Hours Through 14 Hours After Administration in Adults with ADHD
    2. ISTA Pharmaceuticals Submits Supplemental New Drug Application to the FDA for Once-Daily XiDay(TM)
    3. Cephalon Announces that FDA Grants Priority Review of its Supplemental New Drug Application for NUVIGIL as a Treatment for Excessive Sleepiness Associated with Jet Lag Disorder
    4. Sanofi Pasteur Submits Supplemental Application for A(H1N1) Pandemic Vaccine to U.S. FDA
    5. Cephalon Submits NUVIGIL Supplemental New Drug Application for the Treatment of Excessive Sleepiness Associated with Jet Lag Disorder
    6. FDA Grants Priority Review of a Supplemental Biologics License Application for Cinryze(TM) C1 Inhibitor (Human) as Treatment for Acute Attacks of Hereditary Angioedema (HAE)
    7. Anesiva Announces FDA Approval of Supplemental New Drug Application to Expand Zingo(TM) Indication
    8. CTI to Meet With the FDA to Discuss Filing of a Supplemental Biologics License Application for Zevalin(R)
    9. Lilly Submits Cymbalta(R) Supplemental New Drug Application for Chronic Pain to U.S. Food and Drug Administration
    10. Supplemental New Drug Application for PREZISTA(TM) Submitted to U.S. Food and Drug Administration
    11. FDA Accepts Wyeths Supplemental New Drug Application for Tygacil for the Treatment of Patients with Community-Acquired Pneumonia
    Post Your Comments:
    (Date:11/26/2015)... 2015 Research and Markets ( ) has ... Market Outlook to 2019 - Rise in Cardiac Disorders and ... report to their offering. Boston ... scientific and others. --> The ... Boston scientific and others. ...
    (Date:11/26/2015)... -- Research and Markets ( ) has ... Horizons and Growth Strategies in the Japanese Therapeutic ... Forecasts, Competitive Intelligence, Emerging Opportunities" report to ... --> This new 247-page report provides ... monitoring market, including emerging tests, technologies, instrumentation, sales ...
    (Date:11/26/2015)... DUBLIN , November 26, 2015 ... has announced the addition of the  ... in the Global Cell Surface Testing ... Opportunities" report to their offering.  ... the addition of the  "2016 Future ...
    Breaking Medicine Technology:
    (Date:11/27/2015)... ... November 27, 2015 , ... ... convenient way to dispense prescription medications at home, so he invented the patent-pending ... monitor and dispense prescription medications. In doing so, it could help to prevent ...
    (Date:11/27/2015)... ... , ... MPWH, the No.1 Herpes-only dating community in the world, revealed that over 50% of ... than 3.7 billion people under the age of 50 – or 67% of the population ... global estimates of HSV-1 infection . , "The data shocks us highly!" said Michelle ...
    (Date:11/27/2015)... ... November 27, 2015 , ... ... online platform for mental health and wellness consultation, has collaborated with a leading ... bridge the knowledge gap experienced by parents and bring advice from parenting experts ...
    (Date:11/27/2015)... ... November 27, 2015 , ... Indosoft ... announces the incorporation of Asterisk 11 LTS (Long Term Support) into its Q-Suite ... LTS brings Q-Suite 5.10 up-to-date with a version of Asterisk that will receive ...
    (Date:11/26/2015)... ... 2015 , ... The Catalent Applied Drug Delivery Institute today ... dose form selection in early phase drug development. The first of these is ... together the UK’s emerging life sciences companies, corporate partners, and investors, at Milton ...
    Breaking Medicine News(10 mins):